Hospital Universitario de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2019

  1. Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology

    npj Precision Oncology, Vol. 3, Núm. 1

2016

  1. Lack of association of the CEP72 RS924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 100-102

  2. Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia

    Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741

2015

  1. Coexistence of mixed phenotype Creutzfeldt-Jakob disease, Lewy body disease and argyrophilic grain disease plus histological features of possible Alzheimer's disease: A multi-protein disorder in an autopsy case

    Neuropathology, Vol. 35, Núm. 1, pp. 56-63

2010

  1. Breast and ovarian cancer risk evaluation in families with a disease-causing mutation in BRCA1/2

    Journal of Community Genetics, Vol. 1, Núm. 2, pp. 91-99

  2. LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not

    Familial Cancer

2007

  1. CHEK2 1100delC is present in familial breast cancer cases of the Basque Country [2]

    Breast Cancer Research and Treatment

  2. Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: Implications for genetic counselling

    Breast Cancer Research and Treatment, Vol. 106, Núm. 2, pp. 255-262